It seemed a forgone conclusion that Commonwealth Bank of Australia (ASX: CBA) would win the race to $100 last month, but biotech stock CSL Limited (ASX: CSL) has opened up a handy lead in the past few days.
In lunchtime trading, CSL shares are changing hands at around $95.57 per share, compared to CBA's shares on $93.94 and Cochlear Limited (ASX: COH) on $90.20.
In an interesting development, Macquarie Group Ltd (ASX: MQG) has seen its shares climb to $81.55, while another contender, Ramsay Health Care Limited (ASX: RHC) is still a fair way off the pace at $67.30.
As you can see from the chart below tracking their share prices since mid-February, CSL has taken the lead twice from CBA, including last week.
Source: Google Finance
My money's on CSL getting to $100 first. What about you?